Research suggests that intranasal nanosuspensions offer a promising way to formulate and deliver drugs that are poorly soluble in water to patients with chronic conditions.
Anirudh Gautam
Advertisement
Anirudh Gautam is senior director of R&D, Dr. Reddy’s Switzerland.
Articles by Anirudh Gautam
Advertisement
Latest Updated Articles
Assessment of Nanosuspension Formulation for Intranasal AdministrationPublished: September 3rd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
Challenges for the Global Manufacturing of Vaccines
4
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
5
